Loading…
Role of the inhibitor of serine peptidase 2
Trypanosoma brucei rhodesiense is one of the causative agents of Human African Trypanosomiasis (HAT), known as sleeping sickness. The parasite invades the central nervous system and causes severe encephalitis that is fatal if left untreated. We have previously identified ecotin-like inhibitors of se...
Saved in:
Published in: | PLoS neglected tropical diseases 2021-06, Vol.15 (6) |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 6 |
container_start_page | |
container_title | PLoS neglected tropical diseases |
container_volume | 15 |
creator | Grab, Dennis J Goundry, Amy Costa, Tatiana F. R Mottram, Jeremy C Levy, David Jessula Novo, Carlos Mendes Laires, Raquel S. S Lima, Ana Paula C. A |
description | Trypanosoma brucei rhodesiense is one of the causative agents of Human African Trypanosomiasis (HAT), known as sleeping sickness. The parasite invades the central nervous system and causes severe encephalitis that is fatal if left untreated. We have previously identified ecotin-like inhibitors of serine peptidases, named ISPs, in trypanosomatid parasitic protozoa. Here, we investigated the role of ISP2 in bloodstream form T. b. rhodesiense. We generated gene-deficient mutants lacking ISP2 ([DELTA]isp2), which displayed a growth profile in vitro similar to that of wild-type (WT) parasites. C57BL/6 mice infected with [DELTA]isp2 displayed lower blood parasitemia, a delayed hind leg pathological phenotype and survived longer. The immune response was examined at two time-points that corresponded with two peaks of parasitemia. At 4 days, the spleens of [DELTA]isp2-infected mice had a greater percentage of NOS2.sup.+ myeloid cells, IFN-[gamma].sup.+ -NK cells and increased TNF-[alpha] compared to those infected with WT and parasites re-expressing ISP2 ([DELTA]isp2:ISP2). By 13 days the increased NOS2.sup.+ population was sustained in [DELTA]isp2-infected mice, along with increased percentages of monocyte-derived dendritic cells, as well as CD19.sup.+ B lymphocytes, and CD8.sup.+ and CD4.sup.+ T lymphocytes. Taken together, these findings indicate that ISP2 contributes to T. b. rhodesiense virulence in mice and attenuates the inflammatory response during early infection. |
format | article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_healthsolutions_A668346702</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A668346702</galeid><sourcerecordid>A668346702</sourcerecordid><originalsourceid>FETCH-gale_healthsolutions_A6683467023</originalsourceid><addsrcrecordid>eNpjYeA0tDQ21TUyNzLnYOAqLs4yMDC1NLUw5GTQDsrPSVXIT1MoyUhVyMzLyEzKLMkvAgkUpxZl5qUqFKQWlGSmJBanKhjxMLCmJeYUp_JCaW4GNTfXEGcP3fTEnNT4jNTEnJKM4vyc0pLM_LzieEczMwtjEzNzAyNjohUCAOWFMlw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Role of the inhibitor of serine peptidase 2</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Grab, Dennis J ; Goundry, Amy ; Costa, Tatiana F. R ; Mottram, Jeremy C ; Levy, David Jessula ; Novo, Carlos Mendes ; Laires, Raquel S. S ; Lima, Ana Paula C. A</creator><creatorcontrib>Grab, Dennis J ; Goundry, Amy ; Costa, Tatiana F. R ; Mottram, Jeremy C ; Levy, David Jessula ; Novo, Carlos Mendes ; Laires, Raquel S. S ; Lima, Ana Paula C. A</creatorcontrib><description>Trypanosoma brucei rhodesiense is one of the causative agents of Human African Trypanosomiasis (HAT), known as sleeping sickness. The parasite invades the central nervous system and causes severe encephalitis that is fatal if left untreated. We have previously identified ecotin-like inhibitors of serine peptidases, named ISPs, in trypanosomatid parasitic protozoa. Here, we investigated the role of ISP2 in bloodstream form T. b. rhodesiense. We generated gene-deficient mutants lacking ISP2 ([DELTA]isp2), which displayed a growth profile in vitro similar to that of wild-type (WT) parasites. C57BL/6 mice infected with [DELTA]isp2 displayed lower blood parasitemia, a delayed hind leg pathological phenotype and survived longer. The immune response was examined at two time-points that corresponded with two peaks of parasitemia. At 4 days, the spleens of [DELTA]isp2-infected mice had a greater percentage of NOS2.sup.+ myeloid cells, IFN-[gamma].sup.+ -NK cells and increased TNF-[alpha] compared to those infected with WT and parasites re-expressing ISP2 ([DELTA]isp2:ISP2). By 13 days the increased NOS2.sup.+ population was sustained in [DELTA]isp2-infected mice, along with increased percentages of monocyte-derived dendritic cells, as well as CD19.sup.+ B lymphocytes, and CD8.sup.+ and CD4.sup.+ T lymphocytes. Taken together, these findings indicate that ISP2 contributes to T. b. rhodesiense virulence in mice and attenuates the inflammatory response during early infection.</description><identifier>ISSN: 1935-2727</identifier><language>eng</language><publisher>Public Library of Science</publisher><subject>African trypanosomiasis ; Development and progression ; Host-parasite relationships ; Inflammation ; Parasitological research ; Physiological aspects ; Protease inhibitors ; Trypanosoma brucei ; Virulence (Microbiology)</subject><ispartof>PLoS neglected tropical diseases, 2021-06, Vol.15 (6)</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Grab, Dennis J</creatorcontrib><creatorcontrib>Goundry, Amy</creatorcontrib><creatorcontrib>Costa, Tatiana F. R</creatorcontrib><creatorcontrib>Mottram, Jeremy C</creatorcontrib><creatorcontrib>Levy, David Jessula</creatorcontrib><creatorcontrib>Novo, Carlos Mendes</creatorcontrib><creatorcontrib>Laires, Raquel S. S</creatorcontrib><creatorcontrib>Lima, Ana Paula C. A</creatorcontrib><title>Role of the inhibitor of serine peptidase 2</title><title>PLoS neglected tropical diseases</title><description>Trypanosoma brucei rhodesiense is one of the causative agents of Human African Trypanosomiasis (HAT), known as sleeping sickness. The parasite invades the central nervous system and causes severe encephalitis that is fatal if left untreated. We have previously identified ecotin-like inhibitors of serine peptidases, named ISPs, in trypanosomatid parasitic protozoa. Here, we investigated the role of ISP2 in bloodstream form T. b. rhodesiense. We generated gene-deficient mutants lacking ISP2 ([DELTA]isp2), which displayed a growth profile in vitro similar to that of wild-type (WT) parasites. C57BL/6 mice infected with [DELTA]isp2 displayed lower blood parasitemia, a delayed hind leg pathological phenotype and survived longer. The immune response was examined at two time-points that corresponded with two peaks of parasitemia. At 4 days, the spleens of [DELTA]isp2-infected mice had a greater percentage of NOS2.sup.+ myeloid cells, IFN-[gamma].sup.+ -NK cells and increased TNF-[alpha] compared to those infected with WT and parasites re-expressing ISP2 ([DELTA]isp2:ISP2). By 13 days the increased NOS2.sup.+ population was sustained in [DELTA]isp2-infected mice, along with increased percentages of monocyte-derived dendritic cells, as well as CD19.sup.+ B lymphocytes, and CD8.sup.+ and CD4.sup.+ T lymphocytes. Taken together, these findings indicate that ISP2 contributes to T. b. rhodesiense virulence in mice and attenuates the inflammatory response during early infection.</description><subject>African trypanosomiasis</subject><subject>Development and progression</subject><subject>Host-parasite relationships</subject><subject>Inflammation</subject><subject>Parasitological research</subject><subject>Physiological aspects</subject><subject>Protease inhibitors</subject><subject>Trypanosoma brucei</subject><subject>Virulence (Microbiology)</subject><issn>1935-2727</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNpjYeA0tDQ21TUyNzLnYOAqLs4yMDC1NLUw5GTQDsrPSVXIT1MoyUhVyMzLyEzKLMkvAgkUpxZl5qUqFKQWlGSmJBanKhjxMLCmJeYUp_JCaW4GNTfXEGcP3fTEnNT4jNTEnJKM4vyc0pLM_LzieEczMwtjEzNzAyNjohUCAOWFMlw</recordid><startdate>20210621</startdate><enddate>20210621</enddate><creator>Grab, Dennis J</creator><creator>Goundry, Amy</creator><creator>Costa, Tatiana F. R</creator><creator>Mottram, Jeremy C</creator><creator>Levy, David Jessula</creator><creator>Novo, Carlos Mendes</creator><creator>Laires, Raquel S. S</creator><creator>Lima, Ana Paula C. A</creator><general>Public Library of Science</general><scope/></search><sort><creationdate>20210621</creationdate><title>Role of the inhibitor of serine peptidase 2</title><author>Grab, Dennis J ; Goundry, Amy ; Costa, Tatiana F. R ; Mottram, Jeremy C ; Levy, David Jessula ; Novo, Carlos Mendes ; Laires, Raquel S. S ; Lima, Ana Paula C. A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-gale_healthsolutions_A6683467023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>African trypanosomiasis</topic><topic>Development and progression</topic><topic>Host-parasite relationships</topic><topic>Inflammation</topic><topic>Parasitological research</topic><topic>Physiological aspects</topic><topic>Protease inhibitors</topic><topic>Trypanosoma brucei</topic><topic>Virulence (Microbiology)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grab, Dennis J</creatorcontrib><creatorcontrib>Goundry, Amy</creatorcontrib><creatorcontrib>Costa, Tatiana F. R</creatorcontrib><creatorcontrib>Mottram, Jeremy C</creatorcontrib><creatorcontrib>Levy, David Jessula</creatorcontrib><creatorcontrib>Novo, Carlos Mendes</creatorcontrib><creatorcontrib>Laires, Raquel S. S</creatorcontrib><creatorcontrib>Lima, Ana Paula C. A</creatorcontrib><jtitle>PLoS neglected tropical diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grab, Dennis J</au><au>Goundry, Amy</au><au>Costa, Tatiana F. R</au><au>Mottram, Jeremy C</au><au>Levy, David Jessula</au><au>Novo, Carlos Mendes</au><au>Laires, Raquel S. S</au><au>Lima, Ana Paula C. A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of the inhibitor of serine peptidase 2</atitle><jtitle>PLoS neglected tropical diseases</jtitle><date>2021-06-21</date><risdate>2021</risdate><volume>15</volume><issue>6</issue><issn>1935-2727</issn><abstract>Trypanosoma brucei rhodesiense is one of the causative agents of Human African Trypanosomiasis (HAT), known as sleeping sickness. The parasite invades the central nervous system and causes severe encephalitis that is fatal if left untreated. We have previously identified ecotin-like inhibitors of serine peptidases, named ISPs, in trypanosomatid parasitic protozoa. Here, we investigated the role of ISP2 in bloodstream form T. b. rhodesiense. We generated gene-deficient mutants lacking ISP2 ([DELTA]isp2), which displayed a growth profile in vitro similar to that of wild-type (WT) parasites. C57BL/6 mice infected with [DELTA]isp2 displayed lower blood parasitemia, a delayed hind leg pathological phenotype and survived longer. The immune response was examined at two time-points that corresponded with two peaks of parasitemia. At 4 days, the spleens of [DELTA]isp2-infected mice had a greater percentage of NOS2.sup.+ myeloid cells, IFN-[gamma].sup.+ -NK cells and increased TNF-[alpha] compared to those infected with WT and parasites re-expressing ISP2 ([DELTA]isp2:ISP2). By 13 days the increased NOS2.sup.+ population was sustained in [DELTA]isp2-infected mice, along with increased percentages of monocyte-derived dendritic cells, as well as CD19.sup.+ B lymphocytes, and CD8.sup.+ and CD4.sup.+ T lymphocytes. Taken together, these findings indicate that ISP2 contributes to T. b. rhodesiense virulence in mice and attenuates the inflammatory response during early infection.</abstract><pub>Public Library of Science</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1935-2727 |
ispartof | PLoS neglected tropical diseases, 2021-06, Vol.15 (6) |
issn | 1935-2727 |
language | eng |
recordid | cdi_gale_healthsolutions_A668346702 |
source | Publicly Available Content Database; PubMed Central |
subjects | African trypanosomiasis Development and progression Host-parasite relationships Inflammation Parasitological research Physiological aspects Protease inhibitors Trypanosoma brucei Virulence (Microbiology) |
title | Role of the inhibitor of serine peptidase 2 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T10%3A33%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20the%20inhibitor%20of%20serine%20peptidase%202&rft.jtitle=PLoS%20neglected%20tropical%20diseases&rft.au=Grab,%20Dennis%20J&rft.date=2021-06-21&rft.volume=15&rft.issue=6&rft.issn=1935-2727&rft_id=info:doi/&rft_dat=%3Cgale%3EA668346702%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-gale_healthsolutions_A6683467023%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A668346702&rfr_iscdi=true |